恶性血液病患者的生育力保留治疗选择
Fertility-preserving treatment options in patients with malignant hematological diseases.
作者信息
Küçük Mert, Bolaman Ali Zahit, Yavaşoğlu Irfan, Kadıköylü Gürhan
机构信息
Adnan Menderes University, School of Medicine, Department of Obstetrics and Gynecology, Aydın, Turkey.
Adnan Menderes University, School of Medicine, Department of Internal Medicine, Division of Hematology, Aydın, Turkey.
出版信息
Turk J Haematol. 2012 Sep;29(3):207-16. doi: 10.5505/tjh.2012.72681. Epub 2012 Oct 5.
The number of patients of reproductive age diagnosed with various malignant hematological diseases increases every year. These patients undergo chemotherapy, radiotherapy, and various other treatments that may have gonadotoxic effects. The life expectancy of these patients is increasing rapidly due to the variety of treatment options. As such, an increasing number of patients-as well as their parents and spouses-express their concerns about the patient's fertility post treatment. In the present review it was aimed to provide an overview of current fertility-preserving treatment options and the future of fertility preservation.
每年被诊断患有各种恶性血液病的育龄患者数量都在增加。这些患者接受化疗、放疗和其他可能具有性腺毒性作用的治疗。由于治疗选择的多样性，这些患者的预期寿命正在迅速提高。因此，越来越多的患者以及他们的父母和配偶表达了对患者治疗后生育能力的担忧。在本综述中，旨在概述当前的生育力保存治疗选择以及生育力保存的未来。
Zotero 插件